Intended for healthcare professionals


Treating major depression in children and adolescents

BMJ 2004; 328 doi: (Published 26 February 2004) Cite this as: BMJ 2004;328:525

Use of selective serotonin reuptake inhibitors needs urgent clarification

  1. Andrew Herxheimer, emeritus fellow (
  1. UK Cochrane Centre London N3 2NL

    EDITOR—Ramchandani's editorial focuses entirely on the use of selective serotonin reuptake inhibitors in the treatment of major depressive disorder, just as did the statements of the chairman of the Committee on Safety of Medicines on which he comments.1 Did he not think it odd that the statement said nothing about obsessive-compulsive …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription